BELLRING BRANDS INC (BRBR)

US07831C1036 - Common Stock

76.49  +2.08 (+2.8%)

After market: 76.49 0 (0%)

Fundamental Rating

5

Taking everything into account, BRBR scores 5 out of 10 in our fundamental rating. BRBR was compared to 36 industry peers in the Personal Care Products industry. BRBR scores excellent on profitability, but there are some minor concerns on its financial health. While showing a medium growth rate, BRBR is valued expensive at the moment.



7

1. Profitability

1.1 Basic Checks

In the past year BRBR was profitable.
In the past year BRBR had a positive cash flow from operations.
Of the past 5 years BRBR 4 years were profitable.
BRBR had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

BRBR's Return On Assets of 27.47% is amongst the best of the industry. BRBR outperforms 97.14% of its industry peers.
BRBR has a Return On Invested Capital of 45.91%. This is amongst the best in the industry. BRBR outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BRBR is significantly above the industry average of 13.26%.
The 3 year average ROIC (33.84%) for BRBR is below the current ROIC(45.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 27.47%
ROE N/A
ROIC 45.91%
ROA(3y)13.18%
ROA(5y)12.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)33.84%
ROIC(5y)30.38%

1.3 Margins

Looking at the Profit Margin, with a value of 11.55%, BRBR belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
BRBR's Profit Margin has declined in the last couple of years.
BRBR has a better Operating Margin (18.49%) than 88.57% of its industry peers.
BRBR's Operating Margin has improved in the last couple of years.
The Gross Margin of BRBR (34.37%) is worse than 74.29% of its industry peers.
In the last couple of years the Gross Margin of BRBR has remained more or less at the same level.
Industry RankSector Rank
OM 18.49%
PM (TTM) 11.55%
GM 34.37%
OM growth 3Y1.36%
OM growth 5Y3.6%
PM growth 3Y61.03%
PM growth 5Y-3.08%
GM growth 3Y-2.39%
GM growth 5Y-1.07%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BRBR is creating value.
BRBR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 9.83 indicates that BRBR is not in any danger for bankruptcy at the moment.
BRBR has a better Altman-Z score (9.83) than 91.43% of its industry peers.
BRBR has a debt to FCF ratio of 3.43. This is a good value and a sign of high solvency as BRBR would need 3.43 years to pay back of all of its debts.
The Debt to FCF ratio of BRBR (3.43) is better than 74.29% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.43
Altman-Z 9.83
ROIC/WACC5.25
WACC8.75%

2.3 Liquidity

BRBR has a Current Ratio of 2.67. This indicates that BRBR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.67, BRBR is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
BRBR has a Quick Ratio of 1.52. This is a normal value and indicates that BRBR is financially healthy and should not expect problems in meeting its short term obligations.
BRBR has a better Quick ratio (1.52) than 62.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 1.52

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 46.21% over the past year.
The Earnings Per Share has been growing by 27.55% on average over the past years. This is a very strong growth
EPS 1Y (TTM)46.21%
EPS 3Y27.55%
EPS 5YN/A
EPS Q2Q%24.39%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%17.6%

3.2 Future

Based on estimates for the next years, BRBR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.59% on average per year.
BRBR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.41% yearly.
EPS Next Y11.57%
EPS Next 2Y21.09%
EPS Next 3Y12.26%
EPS Next 5Y10.59%
Revenue Next Year10.96%
Revenue Next 2Y10.78%
Revenue Next 3Y9.87%
Revenue Next 5Y8.41%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 39.63, BRBR can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as BRBR.
When comparing the Price/Earnings ratio of BRBR to the average of the S&P500 Index (28.65), we can say BRBR is valued slightly more expensively.
BRBR is valuated quite expensively with a Price/Forward Earnings ratio of 35.52.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BRBR is on the same level as its industry peers.
BRBR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.56.
Industry RankSector Rank
PE 39.63
Fwd PE 35.52

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BRBR.
The rest of the industry has a similar Price/Free Cash Flow ratio as BRBR.
Industry RankSector Rank
P/FCF 40.68
EV/EBITDA 26.07

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BRBR does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of BRBR may justify a higher PE ratio.
A more expensive valuation may be justified as BRBR's earnings are expected to grow with 12.26% in the coming years.
PEG (NY)3.43
PEG (5Y)N/A
EPS Next 2Y21.09%
EPS Next 3Y12.26%

0

5. Dividend

5.1 Amount

No dividends for BRBR!.
Industry RankSector Rank
Dividend Yield N/A

BELLRING BRANDS INC

NYSE:BRBR (11/21/2024, 4:15:01 PM)

After market: 76.49 0 (0%)

76.49

+2.08 (+2.8%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.89B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 39.63
Fwd PE 35.52
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)3.43
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 27.47%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 18.49%
PM (TTM) 11.55%
GM 34.37%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.67
Quick Ratio 1.52
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)46.21%
EPS 3Y27.55%
EPS 5Y
EPS Q2Q%
EPS Next Y11.57%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y